A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang, Sung Hae | - |
dc.contributor.author | Jun, Jae Bum | - |
dc.contributor.author | Lee, Yun Jong | - |
dc.contributor.author | Kang, Tae Young | - |
dc.contributor.author | Moon, Ki Won | - |
dc.contributor.author | Ju, Ji Hyeon | - |
dc.contributor.author | Kang, Seong Wook | - |
dc.contributor.author | Choi, In Ah | - |
dc.contributor.author | Park, Yong-Beom | - |
dc.contributor.author | Lee, Seung Geun | - |
dc.contributor.author | Lee, Shin-Seok | - |
dc.contributor.author | Heo, Nam Hun | - |
dc.contributor.author | Lee, Eun Bong | - |
dc.date.accessioned | 2022-05-24T01:49:58Z | - |
dc.date.available | 2022-05-24T01:49:58Z | - |
dc.date.issued | 2021-12 | - |
dc.identifier.issn | 1462-0324 | - |
dc.identifier.issn | 1462-0332 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20767 | - |
dc.description.abstract | Objectives. To assess the efficacy of an endothelin receptor antagonist (ERA) and phosphodiesterase type5 inhibitors (PDE5is) for treating SSc-related digital ulcers (DUs). Methods. This prospective, multicentre, observational cohort study recruited patients with active SSc-related DUs from 13 medical centres in South Korea. The primary outcome was time to cardinal ulcer (CU) healing. A secondary outcome was time to new DU occurrence. Patients were followed up 4, 8, 12 and 24 weeks after treatment initiation. Results. Sixty-three patients were analysed. Their mean age was 49.9 years (S.D. 11.4) and 49 were female. Twenty-eight had limited SSc. Forty-nine patients received ERA, 11 received a PDE5i (9 sildenafil, 1 udenafil and 1 tadalafil) and 3 received other medication. The hazard ratio (HR) for time to CU healing in the ERA group vs the PDE5i group was 0.75 (95% CI 0.35, 1.64; P = 0.47) in an unadjusted model and 0.80 (95% CI 0.36, 1.78; P = 0.59) in a model adjusted for age, sex, use of calcium channel blockers (CCBs), total DU number and initial CU area. The HR for new DU development in the ERA group vs the PDE5i group was 0.39 (95% CI 0.16, 0.93; P = 0.03) in an unadjusted model and 0.32 (95% CI 0.13, 0.81; P = 0.02) in an adjusted model. No patients receiving CCBs developed new DUs at 24 weeks. Conclusion. Time to CU healing is comparable for ERA and PDE5i. ERAs are more effective in reducing new DU occurrence than PDE5is. CCBs may be effective as a background medication. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Oxford University Press | - |
dc.title | A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1093/rheumatology/keab147 | - |
dc.identifier.scopusid | 2-s2.0-85122331565 | - |
dc.identifier.wosid | 000746212300051 | - |
dc.identifier.bibliographicCitation | Rheumatology, v.60, no.12, pp 5814 - 5819 | - |
dc.citation.title | Rheumatology | - |
dc.citation.volume | 60 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 5814 | - |
dc.citation.endPage | 5819 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | RAYNAUDS-PHENOMENON | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | ILOPROST | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | SILDENAFIL | - |
dc.subject.keywordPlus | MACITENTAN | - |
dc.subject.keywordPlus | SECONDARY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | BOSENTAN | - |
dc.subject.keywordAuthor | systemic sclerosis | - |
dc.subject.keywordAuthor | digital ulcer | - |
dc.subject.keywordAuthor | treatment | - |
dc.subject.keywordAuthor | clinical trial | - |
dc.subject.keywordAuthor | observational cohort study | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.